F ecal volatile organic compounds (VOCs) are gaseous carbon-based metabolic products that may serve as diagnostic biomarkers for gastrointestinal diseases, including advanced adenomas, colorectal carcinoma, and inflammatory bowel disease. 1, 2 Fecal VOCs are considered to reflect intestinal microbiota composition, which is influenced by external factors including diet, medication, and smoking. 3, 4 However, data on the influence of smoking on VOC composition are not yet available. Our aim was to assess the effect of smoking on fecal VOC composition.
Methods

Study Design
Adult patients scheduled for colonoscopy in the VU University Medical Center (Amsterdam, The Netherlands) were eligible to participate in this study, only patients without endoscopic abnormalities (including polyps, inflammatory bowel disease, diverticula, or colorectal cancer) and antibiotic use in the preceding 3 months were included. All patients were enrolled consecutively between February 2015 and November 2016. Fecal samples were collected at home by the participants in a sterile container before bowel cleansing and subsequent colonoscopy and stored at -20 C until analysis by electronic nose (Cyranose 320; Smiths Detection, Pasadena, CA). The ambient air in the lavatories was not analyzed. Standard demographics and smoking habits were collected by means of a questionnaire. Fecal VOC profiles from current smokers, former smokers, and nonsmokers were compared. This study was approved by the medical ethical committee of the VU University Medical Center.
Electronic Nose and Volatile Organic Compound Analysis
The fecal samples (approximately 0.3 g) were analyzed by means of the Cyranose 320, a portable chemical vapor analyzer containing 32 polymer nanocomposite carbon sensors, as described earlier. 5 
Data Analysis
Analysis was performed using IBM SPSS version 18.0 (IBM, Armonk, NY) statistics 22. Demographic data were compared by chi-square test or 1-way analysis of variance (ANOVA). Principal component analysis was used to recombine the variance of the raw sensor data into 4 principal components, subsequently a 1-way ANOVA test was performed, followed by a Fisher least significant difference post hoc test. A P value less than .05 was considered statistically significant. Selected principal components were used in a canonical discriminant analysis, before being internally cross-validated by means of the leave one out method. Scatter plots for the discrimination between samples were created.
nonsmoker, and former smoker) as determined by 1-way ANOVA (P ¼ .009). Fecal samples from smokers showed a different VOC profile compared with fecal samples from nonsmokers (principal component 1, P ¼ .003). Discrimination of smokers and nonsmokers based on fecal VOC profile was possible with an overall accuracy of 75% and corresponding sensitivity and specificity values of 72.7% and 76.2%, respectively. No statistically significant differences in VOC profile were observed between fecal samples from smokers and former smokers (PC1, P ¼ .083), and between fecal samples from nonsmokers and former smokers (PC1, P ¼ .081) (Figure 1 ).
Discussion
Fecal VOC profiles allowed for discrimination between smokers and nonsmokers. This implies that smoking status should be taken into account when performing fecal VOC analysis.
No statistically significant differences were found between fecal VOC profiles of smokers and former smokers and between fecal VOC profiles of nonsmokers and former smokers. An explanation might be the wide divergence (6 months to 43 years) in smoke-free time in former smokers. In the case of antibiotics, microbiota changes can remain for months or even years, but the microbiome is capable of returning to a composition similar to the original one. 6 Strengths of our study were the standardized matter of fecal sample collection, storage, and VOC analysis, which is essential to obtain a reliable outcome. 5 Furthermore, all patients underwent a colonoscopy, which provided the opportunity to rule out colonic abnormalities and their possible bias.
For future research we should take into account the potential influence of alcohol consumption because this may alter the microbial composition. Moreover, more detailed information about smoking behavior, including the number of cigarettes per day in current smokers and the time until cessation in former smokers, is important to fully understand its influence on fecal VOC outcomes.
In conclusion, fecal VOC profiles as measured by means of an eNose can differentiate smoking status. Therefore, the effect of smoking should be taken into consideration when performing fecal VOC profile analysis.
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